Editorial: ADAM, ADAMTS and Astacin Proteases: Challenges and Breakthroughs in the -Omics Era-Volume II
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Hurskainen T, Hirohata S, Seldin M, Apte S
. ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem. 1999; 274(36):25555-63.
DOI: 10.1074/jbc.274.36.25555.
View
2.
Gellrich A, Scharfenberg F, Peters F, Sammel M, Helm O, Armbrust F
. Characterization of the Cancer-Associated Meprin Βeta Variants G45R and G89R. Front Mol Biosci. 2021; 8:702341.
PMC: 8526939.
DOI: 10.3389/fmolb.2021.702341.
View
3.
Dubail J, Apte S
. Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. Matrix Biol. 2015; 44-46:24-37.
DOI: 10.1016/j.matbio.2015.03.001.
View
4.
Moss M, Minond D
. Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation. Mediators Inflamm. 2017; 2017:9673537.
PMC: 5688260.
DOI: 10.1155/2017/9673537.
View
5.
Zhang Y, Wang G, Ma L, Wang C, Wang L, Guo Y
. miR-137 suppresses cell growth and extracellular matrixdegradation through regulating ADAMTS-5 in chondrocytes. Am J Transl Res. 2019; 11(11):7027-7034.
PMC: 6895521.
View